Alzheimer's News Today Home | Alzheimer's News Today
Nov 4, 2024 · Becoming educated and informed about Alzheimer’s is a good first step. Here you’ll find general information about the disease, including diagnosis, symptoms, and causes. Get informed
News Archives - Alzheimer's News Today
Alzheimer’s in people younger than 65 linked to night light exposure. Higher exposure to outdoor light at night may increase the risk of developing Alzheimer’s disease, especially in people younger than 65, according to a study that drew on Medicare records and …
ALZ-801 for 2 years seen to sustain cognition in early Alzheimer’s
Sep 22, 2023 · ALZ-801 aims to work as a preventive therapy in early Alzheimer’s. Alzheimer’s is marked by the presence of beta-amyloid plaques and tau tangles, which are clumps of two proteins that build up to toxic levels inside brain nerve cells.
Topline results of Phase 3 studies of simufilam for Alzheimer's...
Feb 8, 2024 · The two studies collectively enrolled 1,929 people with mild to moderate Alzheimer’s and the U.S. Food and Drug Administration (FDA) has confirmed they could support an application for simufilam’s approval if the results are positive.
About Us - Alzheimer's News Today
Alzheimer’s News Today is a digital platform intended to provide the Alzheimer’s disease community with the most recent news and information on the disease, as well as first-hand community perspectives from our patient and caregiver columnists.
Simufilam found safe in review of ongoing Alzheimer's clinical trials
Sep 26, 2024 · Simufilam is an oral small molecule designed to target filamin A, a protein that forms abnormal clumps in Alzheimer’s and that’s also involved in amyloid-beta and tau clumping. By targeting filamin A, simufilam aims to reduce brain damage and slow disease progression.
Namenda (Memantine) - Alzheimer's News Today
Namenda (memantine) is approved to treat moderate to severe Alzheimer’s, and works by preventing excessive calcium from entering and damaging brain cells.
In early Alzheimer’s, Anavex 2-73 slows cognitive decline...
Sep 15, 2023 · In Alzheimer’s, the amyloid-beta protein forms toxic clumps that disrupt nerve cell function. A brain affected by Alzheimer’s is also marked by neuroinflammation, energy imbalances, and oxidative stress, a type of cellular damage.
Nasal Insulin - Alzheimer's News Today
Two clinical trials are currently testing nasal insulin as a treatment for Alzheimer’s disease. The first, which is no longer recruiting participants, is a year-long Phase 2/3 trial (NCT01767909) looking at the therapeutic effects of nasal insulin in patients with amnestic mild cognitive impairment or mild Alzheimer’s disease. This study is ...
Light the world teal for November’s Alzheimer’s Awareness Month
Oct 31, 2024 · November is National Alzheimer’s Awareness Month, and the Alzheimer’s Foundation of America (AFA) is encouraging those impacted by Alzheimer’s disease — and their supporters — to wear teal and spread the word on social media to educate people.